Christopher Walker

@risk_averse_

Sharing publicly available information and not recommending anything to anybody.

Vrijeme pridruživanja: prosinac 2015.

Tweetovi

Blokirali ste korisnika/cu @risk_averse_

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @risk_averse_

  1. Ponder If You Will, Your Legacy

    Poništi
  2. BioSpace Movers and Shakers, Jan. 31

    Poništi
  3. GeNeuro raises €17.5M for multiple sclerosis clinical trial

    Poništi
  4. Improving CAR-T therapy for cancer by regulating 2 proteins

    Poništi
  5. Mammoth Biosciences nabs $45M for CRISPR drugs, diagnostics work

    Poništi
  6. University of Pennsylvania researchers nab grant for CAR-T prostate cancer test

    Poništi
  7. 4. velj

    4 Lessons From Carlos Ghosn's Great Escape

    Poništi
  8. 4. velj

    Oil Prices Are Headed Much Lower

    Poništi
  9. 4. velj

    Canadian Cannabis Producers See Stocks Slide for 10th Consecutive...

    Poništi
  10. 4. velj

    China Coronavirus Update: An Interview with Infectious Disease Specialist Sean Beckmann

    Poništi
  11. 4. velj

    Sandoz Completes Acquisition of Aspen's Japanese Operations

    Poništi
  12. 4. velj

    How can companies reduce internal and external business risk?

    Poništi
  13. 4. velj

    The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus

    Poništi
  14. 4. velj

    American Cannabis Operator Index Drops 9% in January

    Poništi
  15. 4. velj

    Hashtag Medicine: Coronavirus Fear Goes Viral on Social Media

    Poništi
  16. 4. velj

    Serious infectious disease epidemics such as the current coronavirus outbreak require rapid and effective response.

    Poništi
  17. 3. velj

    Exciting preclinical data and novel mechanism of action for PCLX-001 positions Pacylex well for 2020.

    Poništi
  18. 3. velj

    An Exciting New Mechanism: several reasons PCLX-001 might be a gem

    Poništi
  19. 3. velj

    What Are the Differences Between Lymphocytic and Myelogenous Leukemia?

    Poništi
  20. 3. velj

    Akcea, Pfizer hit midphase goal, but data raise doubts about chances in NAFLD, diabetes

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·